HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marinella Clerico Selected Research

Pneumonia (Pneumonitis)

12/2022The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marinella Clerico Research Topics

Disease

35Multiple Sclerosis
03/2024 - 07/2004
11Relapsing-Remitting Multiple Sclerosis
01/2020 - 07/2004
6COVID-19
01/2023 - 01/2021
4Progressive Multifocal Leukoencephalopathy
05/2021 - 08/2014
3Infections
01/2023 - 01/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2024 - 10/2014
2Breakthrough Infections
01/2023 - 11/2022
2Lymphopenia (Lymphocytopenia)
01/2022 - 12/2017
2Disease Progression
01/2022 - 01/2018
2Sudden Infant Death (SID)
05/2021 - 01/2020
2Sialorrhea
11/2016 - 12/2015
1Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
11/2023
1Polyneuropathies (Polyneuropathy)
11/2023
1Pneumonia (Pneumonitis)
12/2022
1Myasthenia Gravis
12/2021
1Stroke (Strokes)
03/2021
1Inflammation (Inflammations)
02/2016
1Nervous System Diseases (Neurological Disorders)
12/2015
1Deglutition Disorders (Dysphagia)
12/2015
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2014
1Friedreich Ataxia (Friedreich's Ataxia)
10/2014
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
09/2014
1Thymoma (Thymic Carcinoma)
08/2009
1Neoplasms (Cancer)
08/2009
1Thymus Hyperplasia
08/2009
1Necrosis
04/2007

Drug/Important Bio-Agent (IBA)

7Natalizumab (Tysabri)FDA Link
09/2022 - 08/2014
7Alemtuzumab (Campath)FDA Link
01/2022 - 02/2016
6Messenger RNA (mRNA)IBA
01/2023 - 09/2010
6Interferon-betaIBA
01/2017 - 07/2004
5COVID-19 VaccinesIBA
11/2023 - 01/2022
5InterferonsIBA
01/2016 - 07/2004
4Fingolimod Hydrochloride (FTY720)FDA Link
01/2023 - 10/2019
3VaccinesIBA
01/2023 - 05/2022
3ocrelizumabIBA
01/2023 - 01/2021
3Biomarkers (Surrogate Marker)IBA
01/2018 - 09/2014
3CytokinesIBA
02/2016 - 09/2010
2Immunoglobulins (Immunoglobulin)IBA
11/2023 - 08/2009
2Estrogens (Estrogen)FDA Link
10/2019 - 01/2018
2Monoclonal AntibodiesIBA
08/2017 - 04/2017
2Type A Botulinum Toxins (Botox)FDA Link
11/2016 - 12/2015
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2023
1MethylprednisoloneFDA LinkGeneric
01/2023
1Neutralizing AntibodiesIBA
01/2023
1Rituximab (Mabthera)FDA Link
01/2023
1Air Pollutants (Pollutants, Air)IBA
12/2022
1Environmental Pollutants (Pollutants, Environmental)IBA
12/2022
1nitazoxanide (NTZ)FDA Link
09/2022
1CD52 AntigenIBA
01/2022
1AntigensIBA
10/2021
1Dimethyl FumarateIBA
01/2020
1Estradiol (Delestrogen)FDA LinkGeneric
01/2019
1Progestins (Progestagens)IBA
01/2019
1Cholinergic Antagonists (Anticholinergics)IBA
11/2016
1Interferon beta-1aFDA Link
02/2016
1incobotulinumtoxinAFDA Link
12/2015
1Therapeutic UsesIBA
12/2015
1Interleukin-22 (IL-22)IBA
12/2014
1Histone Deacetylase InhibitorsIBA
10/2014
1AlbuminsIBA
09/2014
1CreatinineIBA
09/2014
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2012
1ChemokinesIBA
09/2010
1Immunosuppressive Agents (Immunosuppressants)IBA
08/2009
1Interferon beta-1b (Betaseron)FDA Link
09/2008
1Matrix Metalloproteinases (MMPs)IBA
04/2007
1Immunoglobulin G (IgG)IBA
04/2007
1InterleukinsIBA
04/2007
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
04/2007

Therapy/Procedure

16Therapeutics
11/2023 - 07/2004
3Injections
11/2016 - 12/2015
1Mediterranean Diet
03/2024
1Continuity of Patient Care
12/2021
1Secondary Prevention
03/2021
1Analgesia
01/2019
1Thymectomy
08/2009
1Drug Tapering
07/2004